NCT03393208View on ClinicalTrials.gov

Glucophage Immediate Release (GIR) China Bioequivalence Study

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

January 29, 2018

Study Completion Date

January 29, 2018

Conditions
Healthy
Interventions
DRUG

Test GIR

Participants received 500 milligrams (mg) test GIR in fasting or fed state on either Day 1 (Treatment Period 1) or Day 8 (Treatment Period 2).

DRUG

Reference GIR

Participants received 500 mg reference GIR in fasting or fed state on either Day 1 (Treatment Period 1) or Day 8 (Treatment Period 2).

Trial Locations (1)

100053

Xuanwu Hospital, Beijing

All Listed Sponsors
lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT03393208 - Glucophage Immediate Release (GIR) China Bioequivalence Study | Biotech Hunter | Biotech Hunter